Generic low molecular weight heparins: A significant dilemma

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 4, 2005, Pages 363-366

  Fareed, Jawed ^a   Iqbal, Omer ^a   Nader, Helena ^b,d   Mousa, Shaker ^c   Wahi, Rakesh ^c   Coyne, Erwin ^a   Bick, Rodger L ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Albany College of Pharmacy ^*

^d ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; GENERIC DRUG; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; DRUG APPROVAL; DRUG MANUFACTURE; DRUG QUALITY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEMOSTASIS; NUCLEAR MAGNETIC RESONANCE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOSIS;

EID: 27544475368     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100401     Document Type: Editorial

References (0)